Animal studies have shown intratumoral knockdown of EZH2 promotes tumour regression, this observation being confirmed in HCC cell lines which lose their tumour initiating properties in the absence of EZH2 [89]. The gene discussed is EZH2; the disease is hepatocellular carcinoma.